(19)

(11)

EP 4 404 913 A1

(12)

(43) Date of publication: 31.07.2024 Bulletin 2024/31 (21) Application number: 22793529.3 (22) Date of filing: 21.09.2022

(51) International Patent Classification (IPC):  A61K 9/00(2006.01) A61K 47/20(2006.01) A61K 9/10(2006.01) A61K 47/34(2017.01) (52) Cooperative Patent Classification (CPC): A61K 9/0024; A61K 9/10; A61K 47/34; A61K 47/20; A61K 31/519; A61P 25/18; A23L 3/44; A23L 11/05 (86) International application number: PCT/EP2022/076186 (87) International publication number: WO 2023/046731 (30.03.2023 Gazette 2023/13)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA ME Designated Validation States: KH MA MD TN (30) Priority: 21.09.2021 US 202163246446 P 16.02.2022 US 202263310884 P (71) Applicant: Laboratorios Farmacéuticos Rovi, S.A. 28037 Madrid (ES)	(72) Inventors: GUTIERRO ADURIZ, Ibon 18007 Granada (ES) FRANCO RODRIGUEZ, Guillermo 28037 Madrid (ES) (74) Representative: Elzaburu S.L.P.  Edificio Torre de Cristal Paseo de la Castellana 259 C, planta 28 28046 Madrid 28046 Madrid (ES)